Digital Therapeutic for Long COVID

About Mymee

Mymee is a New York-based digital therapeutics company founded in 2016, targeting the large and underserved market of patients with autoimmune diseases and long COVID who experience uncontrolled symptoms. Its core offering is a personalized care platform combining a mobile app, a proprietary data analytics engine, and dedicated health coaches to help patients identify and avoid individual triggers, leading to clinically validated reductions in pain, fatigue, and other symptoms. The company has garnered support from industry leaders and published peer-reviewed research, positioning itself as a novel, data-driven adjunct to conventional autoimmune care.

Therapeutic Areas